A
pregnancy test is used to verify if a woman is pregnant. Pregnancy test is done
by analyzing a sample of a woman's blood or urine for the presence of human
chorionic gonadotropin (hCG). hCG is a hormone produced by placenta and is
usually present in a woman's body when she is pregnant. On the other hand,
ovulation test is capable of detecting an uptick in luteinizing hormone (LH) to
decide the most favorable time for conceiving children.
According
to study, “Asia
Pacific Pregnancy & Ovulation Testing Market Research Report: By Type (hCG
Detection, Ovulation Testing), by Mode of Purchase (OTC Testing, Prescription
Testing), End-User (Hospitals & Clinics, Fertility Centers, Others) -
Global Forecast Till 2023” the key companies that are currently working
in the Asia Pacific pregnancy & ovulation testing market are Gregory
Pharmaceutical Holdings, Inc., TaiDoc Technology & Corporation, Proctor
& Gamble, Mankind Pharma Ltd., Fairhaven Health, LLC, Geratherm Medical AG,
Quidel Corporation, Cadila Healthcare Limited, SPD Swiss Precision Diagnostics
GmbH, Piramal Enterprises Ltd., Church & Dwight Co., Inc., Alpha
Pharmaceuticals, Hicks Thermometers India Limited, Reddy’s Laboratories, SMB
Corporation of India, Sri Pharmacare.
Based
on type, Asia Pacific pregnancy & ovulation testing market is segmented
into pregnancy testing (HCG detection) and ovulation testing. The ovulation
testing segment is further sub-segmented into ovulation prediction kits and
fertility monitors. Additionally, pregnancy testing segment is further
sub-segmented into urine-based testing and blood based testing. Based on type
of blood test, market is segmented into quantitative and qualitative. Based on
product type, market is segmented into pregnancy rapid test kits and ovulation
test kits. Pregnancy rapid test kits include linear-indicator devices
(strip/dip sticks, cassettes and mid-stream devices) and digital devices. Based
on mode of purchase, market is segmented into prescription testing and
non-prescription or OTC testing. The non-prescription testing mode of purchase
is anticipated to experience significant growth as a result of preference for
home pregnancy tests & privacy concerns among women. In addition, based on
end-user, market is segmented into pharmacies, gynecology & fertility centers,
drug stores, online sales, hospitals & clinics and others.
The
Asia Pacific pregnancy & ovulation testing market is driven by emergence in
advanced technology with high accuracy, followed by decline in fertility rate,
rise in demand for prompt diagnosis, change in lifestyles, increase in
prevalence of infertility & gynaecological disorders, unplanned pregnancy
rate, increase in awareness of fertility tests, and easy availability of
ovulation & pregnancy monitors on e-commerce websites. However, high cost
associated with ovulation tests and low adaptation rate may impact the market.
Moreover, growth in awareness about pregnancy & ovulation testing is a key
opportunity for market.
Based
on geography, China holds the most considerable share in Asia Pacific pregnancy
& ovulation testing market owing to increase in gynaecological disorders
and high population base in the country. The increase in acceptance of home
testing kits to check the possibility of pregnancy is estimated to stimulate
market demand during the forecast period. It is anticipated that the market
will be reached at US $298.68 billion by 2023.
To
know more, click on the link below:-
Contact
Us:-
Ken
Research
Ankur
Gupta, Head Marketing & Communications
+91-9015378249
No comments:
Post a Comment